UK Markets close in 7 hrs 43 mins

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
52.77+5.94 (+12.68%)
At close: 04:00PM EDT
53.35 +0.58 (+1.10%)
After hours: 06:46PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close46.83
Bid0.00 x 1000
Ask0.00 x 800
Day's range47.05 - 53.08
52-week range25.07 - 139.99
Avg. volume1,240,330
Market cap2.619B
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)-3.15
Earnings date02 Feb 2022 - 07 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est48.50
  • Motley Fool

    Why Twist Bioscience's Shares Rose 25.1% in July

    Shares of Twist Bioscience (NASDAQ: TWST), a biotech company that makes synthetic DNA-based products, including synthetic genes, antibody libraries for drug development and tools for next-generation sample preparation, jumped 25.1% in July, according to according to data from S&P Global Intelligence. On July 14, the company announced that it was launching two monkeypox virus synthetic DNA controls, including the Congo Basin clade (genetic branch) from Central Africa and the West African clade. The second bit of news that helped drive up Twist's shares was that Cathie Wood's ARK Innovation ETF bought an additional 156,417 shares of Twist in July, raising the ETF's number of Twist shares to 6.27 million, making it the second-largest holder of Twist shares.

  • Zacks

    Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) delivered earnings and revenue surprises of 16.92% and 9.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results

    SOUTH SAN FRANCISCO, Calif., August 05, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2022 ended June 30, 2022.